Dice Therapeutics Inc
(DICE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 0 | 0 | 0 | 1,125 | 0 |
| Gross Profit | N/A | N/A | N/A | 1,125 | N/A |
| Operating Expenses | 18,858 | 16,210 | 16,133 | 8,299 | 8,086 |
| Operating Income | -18,858 | -16,210 | -16,133 | -7,174 | -8,086 |
| Interest Expense | 60 | 60 | 60 | 52 | 2 |
| Other Income | 327 | 75 | -1,142 | -137 | 22 |
| Pre-tax Income | -18,591 | -16,195 | -17,335 | -7,363 | -8,066 |
| Net Income Continuous | -18,591 | -16,195 | -17,335 | -7,363 | -8,066 |
| Net Income | $-18,591 | $-16,195 | $-17,335 | $-7,363 | $-8,066 |
| EPS Basic Total Ops | -0.50 | 5.21 | -2.30 | -3.27 | -3.59 |
| EPS Basic Continuous Ops | -0.50 | 5.20 | -2.30 | -3.27 | -3.59 |
| EPS Diluted Total Ops | -0.50 | 5.21 | -2.30 | -3.27 | -3.59 |
| EPS Diluted Continuous Ops | -0.50 | 5.20 | -2.30 | -3.27 | -3.59 |
| EPS Diluted Before Non-Recurring Items | -0.50 | -0.44 | -2.30 | N/A | N/A |
| EBITDA(a) | $-18,310 | $-16,025 | $-15,964 | $-6,940 | $-7,906 |